Search
Amphastar Pharmaceuticals Inc
AMPHAdd to Watchlist
19.940USD
-0.440-2.16%
Close 07-31 16:00（ET）Quotes delayed by 15 min
879.21MMarket Cap
11.66P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Other products
229.65M
31.90%
BAQSIMI
185.36M
25.75%
Primatene Mist
108.67M
15.10%
Epinephrine
70.64M
9.81%
Glucagon
69.08M
9.60%
Other
56.48M
7.85%
By RegionUSD
Name
Revenue
Proportion
United States
681.42M
94.66%
France
35.28M
4.90%
China
3.18M
0.44%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Other products
229.65M
31.90%
BAQSIMI
185.36M
25.75%
Primatene Mist
108.67M
15.10%
Epinephrine
70.64M
9.81%
Glucagon
69.08M
9.60%
Other
56.48M
7.85%